Coronavirus Notebook: Nobel Laureates Press Germany To Back Vaccine IP Waiver

 
• By Ian Schofield
Businessman holding a foldable smartphone with INTELLECTUAL PROPERTY inscription
Pharma firms say IP is essential for innovative R&D on new vaccines • Source: Alamy

More from Europe

More from Geography